Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.
The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD: Ketamine Combined with Written Exposure Therapy” on ...
DETROIT — A team of researchers from Wayne State University was awarded a $1.3 million, three-year grant from the U.S. Department of Defense to study “Advanced wireless augmented reality-enhanced ...
Experiencing trauma can sometimes lead to post-traumatic stress disorder (PTSD). This serious mental health condition is marked by changes in mood, intrusive memories, avoidant behavior, and a ...
Initiating cognitive processing therapy or prolonged exposure (CPT/PE) sessions for post-traumatic stress disorder (PTSD) was associated with lower suicide risk in military veterans in an ...
Researchers at The University of Texas Health Science Center at San Antonio and their collaborators at Emory University have received a $4.9 million grant aimed at significantly improving treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results